Protein and angiogenic dose-response expression of phVEGF-A165 gene in rat myocardium

Journal of Thrombosis and Thrombolysis

Volumn 12, Issue 2, 2001, Pages 151-156

  Sylvén, Christer ^a   Sarkar, Nondita ^a   Wärdell, Eva ^a   Jämsä, Anne ^a   Drvota, Viktor ^a   Blomberg, Pontus ^a   Islam, Khalid Bin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Dose response; Myocardium; Plasmid; VEGF

Indexed keywords

ANGIOGENIC FACTOR; HUMAN VASCULOTROPIN A; PLASMID DNA VASCULOTROPIN A 165; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; ECHOCARDIOGRAPHY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEART MUSCLE; HEART MUSCLE CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MALE; MORPHOLOGY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCAR; VASCULAR TUMOR;

ANIMALS; ANOXIA; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION; GENE THERAPY; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0035682927     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012971421128     Document Type: Article

References (21)

1. Angiogenesis: A dynamic balance of stimulators and inhibitors
2. Mechanisms of angiogenesis
3. Clinical applications of angiogenic growth factors and their inhibitors
4. Cardiovascular gene therapy
5. Rescue of diabetes related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
6. Age-dependent impairment of angiogenesis
7. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
8. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovasculization
9. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
10. Vascular endothelial growth factor and its receptors
11. Direct myocardial transfection in two animal models: Evaluation of parameters affecting gene expression and percutaneous gene delivery
12. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic and for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
13. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium
14. Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors in vivo by ultrasound-guided injection or transcoronary delivery
15. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and tumour formation
16. Intramyocardial injection of DNA encoding vascular endothelial growth factor in a myocardial infarction model
17. VEGF gene delivery to myocardium. Deleterious effects of unregulated expression
18. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
19. 165 plasmid in patients with inoperable angina pectoris
20. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping